BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 18401171)

  • 21. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
    Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
    Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.
    O'Hara R; Sommer B; Way N; Kraemer HC; Taylor J; Murphy G
    J Psychiatr Res; 2008 Feb; 42(3):199-204. PubMed ID: 17250852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly.
    Harwood DG; Barker WW; Ownby RL; Mullan M; Duara R
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1131-9. PubMed ID: 15526312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and severity of microbleeds in a memory clinic setting.
    Cordonnier C; van der Flier WM; Sluimer JD; Leys D; Barkhof F; Scheltens P
    Neurology; 2006 May; 66(9):1356-60. PubMed ID: 16682667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
    Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
    J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
    Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
    Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
    Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
    Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
    Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
    Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
    Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).
    Luck T; Riedel-Heller SG; Luppa M; Wiese B; Wollny A; Wagner M; Bickel H; Weyerer S; Pentzek M; Haller F; Moesch E; Werle J; Eisele M; Maier W; van den Bussche H; Kaduszkiewicz H;
    Acta Psychiatr Scand; 2010 Apr; 121(4):260-72. PubMed ID: 19824992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.
    Bleumink GS; van Duijn CM; Kingma JH; Witteman JC; Hofman A; Stricker BH
    Am Heart J; 2004 Apr; 147(4):685-9. PubMed ID: 15077085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.